SEPN Competitors & Alternatives
Compare Septerna, Inc. Common Stock with similar stocks in the same industry
Biotechnology
SEPN
Main Stock$34.36
Tradestie Score
55
Market Cap
$847.12M
Revenue Growth
120.1%
Analyst Upside
+31.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$18.99
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.53
|
$1.68B | - | 62 | Compare |
|
MNKD
Mannkind Corporation
|
$4.04
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$41.27
|
$1.63B | - | 64 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.17
|
$1.57B | - | 59 | Compare |
|
VCEL
Vericel Corporation
|
$47.49
|
$1.56B | 109.3 | 61 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$98.64
|
$1.55B | - | 59 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$35.54
|
$1.55B | 14.9 | 57 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$35.07
|
$1.55B | - | 62 | Compare |
|
NVAX
Novavax Inc
|
$8.91
|
$1.54B | - | 53 | Compare |
More SEPN Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry